This trial is testing whether a less expensive and simpler pancreatic cancer diagnosis procedure is just as good as the current standard.
1 Primary · 4 Secondary · Reporting Duration: 2 years
Active Control
132 Total Participants · 2 Treatment Groups
Primary Treatment: EUS-FNB without ROSE · No Placebo Group · N/A
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Maryland | 100.0% |
18 - 65 | 100.0% |
Met criteria | 100.0% |